Email this article to a friend Printable Version FREE Email Newsletter
(NaturalNews) In the month after the announcement that the popular diabetes drug Avandia may lead to an increased risk of heart attacks, reports of the drug's side effects from doctors to the federal government tripled.
On May 21, 2007, the New England Journal of Medicine and the FDA released the results of a study which found that rosiglitazone -- marketed as Avandia, or as Avandamet or Avandaryl when mixed with other diabetes drugs -- led to higher risk of heart attacks. Sufferers of Type 2 diabetes, which rosiglitazone is intended to combat, are already at a higher risk of heart disease than the general population.
According to Freedom of Information Act requests by the Associated Press, reporting of side effects from rosiglitazone was three times higher in the 35 days after May 21 than in the 35 days before. For certain effects, the change was even more drastic.
While only five rosiglitazone-related heart attacks were reported in the 35 days before the study, 90 were reported in the days after. Only 11 heart-related hospitalizations were reported before the study; there were 126 after.
According to Dr. Alvin C. Powers, a diabetes specialist at Vanderbilt University, the study probably led to doctors being more aware that their patients' heart problems might be linked to the drug, thus leading to an increase in reporting.
"Now patients and their doctors are much more aware of the possible link between Avandia and cardiovascular disease," Powers said. "This is going to help us going forward to determine whether or not this drug is safe."
Avandia was on the market for eight years before the release of the New England Journal of Medicine Study. However, warnings had been made as early as March 2000 that the drug might not be safe. These warnings were not acted on by the FDA, and the doctor who made them -- John Buse, of the University of North Carolina -- has claimed that he was threatened with legal action by GlaxoSmithKline if he did not recant.
Get articles like this delivered to you FREE in our popular email newsletter
|

(FREE) Thursday evening, Nov. 12 at 6pm Pacific (9pm Eastern), call in to hear the NaturalNews Talk Hour with special guest Dr. Caldwell Esselstyn - "Making Yourself Heart Attack Proof" Register via email to receive call-in number:
|
|
 Explore NaturalPedia.com, the internet's largest natural health encyclopedia of knowledge, covering over 50,000 topics. It's free! Visit NaturalPedia.com.
|
FREE Report: The Five Best Anti-Viral Products to Beat Influenza, Swine Flu, Bird Flu and SARS
• Top anti-viral remedies
• Where to get them now
• Four things to avoid
• Become self-reliant
• Boost your family safety
Click here to read the FREE report now.
|
W.H.O. Declares Global Pandemic Turn FEAR into Confidence!
Listen to the complete 3.5 hour recording on 4 audio CDs of the Health Ranger's Swine Flu Advanced Preparedness Course, covering natural anti-virals, family safety, infrastructure disruptions, quarantine, preparedness gear and much more.
Testimonials:
"Mike Adams' preparedness course turned our fears into confidence. This is POWERFUL information, coming from a trusted source. If you want to save yourself countless hours researching and getting prepared and if you want to do everything in your power to protect your family, I highly recommend the Health Ranger’s Advanced Preparedness Course."
- N. Nelson (Arizona)
"This is packed information no one should miss."
- T. Valenzuela
"Thanks Mike... during this class you covered prevention and preparedness from A to Z with integrity, brave honesty and outstanding knowledge! Thank you for your steadfast, thorough and cool-headed approach to well being. With deep gratitude for your service." - Bev
Available NOW for immediate shipping.
100% satisfaction guarantee
NEW Product: Valley of Longevity Shampoo from the Health Ranger
• 98% Organic
• 100% Natural
• 100% Fragrance Free!
• No SLS
• No Parabens
• No synthetic chemicals
• FREE shipping in U.S. on orders over $75
Click here to read more...
|
|
|